Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: fracture

Glucocorticoid-Induced Osteoporosis

Staff  |  June 1, 2008

Osteoporosis is a condition of weak bone caused by a loss of bone mass and a change in bone structure. Glucocorticoid-induced osteoporosis is a form of osteoporosis caused by taking glucocorticoid medications, such as prednisone (Deltasone, Orasone, etc.), prednisolone (Prelone), dexamethasone (Decadron, Hexadrol), and cortisone (Cortone Acetate). These medications are used to help control many rheumatic diseases, including RA, systemic lupus erythematosus, and polymyalgia rheumatica.

Filed under:ConditionsFrom the CollegeOsteoarthritis and Bone Disorders Tagged with:Diagnostic CriteriaGlucocorticoid-Induced OsteoporosisOsteoporosis

Physician Quality Reporting Initiative (PQRI) Changes for 2008

Staff  |  June 1, 2008

CMS has announced alternative reporting periods and reporting criteria for the 2008 Physician Quality Reporting Initiative (PQRI).

Filed under:From the CollegePractice SupportQuality Assurance/Improvement Tagged with:Centers for Medicare & Medicaid Services (CMS)measuresMedicareMeetingPQRIPracticeQuality

American College of Rheumatology (ACR) on Capitol Hill

From the College  |  May 1, 2008

“By tomorrow night, there will be so many more people on Capitol Hill who know—and are sensitive to—rheumatology and the issues that impact you and your patients. There is no substitute for what you are doing,” says Martha M. Kendrick, a partner at Patton Boggs, LLP, the ACR’s lobbying firm. This is what she told the physician, health professional, and patient participants of the ACR’s 2008 “Advocates for Arthritis” advocacy event—termed a fly-in—before they took their personal stories to the lawmakers on Capitol Hill.

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:Advocates for ArthritisAdvocating with YouCapitol HillCenters for Medicare & Medicaid Services (CMS)CongressLegislationMedicarePolitics

Dr. Wolfe & the National Data Bank for Rheumatic Diseases (NBD)

Norra MacReady  |  April 1, 2008

A private database becomes a national resource

Filed under:Information TechnologyTechnologyTechnology Tagged with:MDPractice tools

The Line Between Boost and Ban

Bruce N. Cronstein, MD  |  April 1, 2008

What makes a performance-enhancing drug taboo?

Filed under:EthicsLegal UpdatesProfessional Topics Tagged with:DrugsPerformance-enhancing drugsSports

Advocacy and More

David A. Fox, MD  |  April 1, 2008

A week in the life of the ACR

Filed under:Legislation & AdvocacyPresident's PerspectiveProfessional Topics Tagged with:AC&RAdvocates for ArthritisCapitol HillCongressLegislationPolitics

Reading Rheum: Which Bone Agent Is Best in High-risk Osteoporosis?

Eric S. Schned, MD  |  March 1, 2008

Handpicked Reviews of Contemporary Literature

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:anabolicbisphosphonatesClinical researchglucocorticoidOsteoporosisrandomized controlled trialReading Rheumrisk

Osteoarthritis Quo Vadis

Roland W. Moskowitz, MD  |  March 1, 2008

Our knowledge of OA has progressed far—does a cure lie ahead?

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Clinical researchosteoarthritis (OA)PainTreatment

Reading Rheum

Maripat Corr, MD; Daniel Hal Solomon, MD, MPH  |  February 1, 2008

Handpicked Reviews of Contemporary Literature

Filed under:Axial SpondyloarthritisResearch Rheum Tagged with:Ankylosing SpondylitisPractice toolsReading RheumTreatment

Carpal Tunnel Syndrome

Staff  |  November 1, 2007

Carpal tunnel syndrome (CTS) is possibly the most common nerve disorder experienced today. It affects 3% to 7% of the population and is usually treatable. Middle-age and older individuals are more likely to develop CTS than younger people, and women develop CTS three times more frequently than men.

Filed under:AnalgesicsConditionsFrom the College Tagged with:Carpal Tunnel SyndromeDiagnostic Criterianonsteroidal antiinflammatory drug (NSAID)Patients

  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences